Your browser doesn't support javascript.
loading
mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects.
Fabricius, Dorit; Ludwig, Carolin; Scholz, Judith; Rode, Immanuel; Tsamadou, Chrysanthi; Jacobsen, Eva-Maria; Winkelmann, Martina; Grempels, Aline; Lotfi, Ramin; Janda, Ales; Körper, Sixten; Adler, Guido; Debatin, Klaus-Michael; Schrezenmeier, Hubert; Jahrsdörfer, Bernd.
Afiliação
  • Fabricius D; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Ludwig C; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Scholz J; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Rode I; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Tsamadou C; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Jacobsen EM; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Winkelmann M; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Grempels A; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Lotfi R; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Janda A; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Körper S; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Adler G; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Debatin KM; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Schrezenmeier H; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
  • Jahrsdörfer B; Division of Immune Cell Therapeutics, Institute of Clinical Transfusion Medicine and Immunogenetics, Helmholtzstrasse 10, 89081 Ulm, Germany.
Vaccines (Basel) ; 9(8)2021 Aug 18.
Article em En | MEDLINE | ID: mdl-34452043
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha